- 15-01-2020AVROBIO Announces Clinical and Regulatory Progress For Gaucher Disease Program
- 10-01-2020PR001 Administered to International Type 2 Gaucher Disease Patient Via Compassionate Use Pathway
- 08-01-2020Prevail Therapeutics Is Recruiting Patients For PROPEL, a Clinical Trial Testing An Investigational Gene Therapy Called PR001 to Treat Parkinson’s Disease In People with GBA Mutations
- 17-12-2019December 2019 Newsletter
LINK TO ONE OF OUR 55 MEMBER ASSOCIATIONS FOR LOCAL SUPPORT, ADVICE AND NEWS
view map
close- Finland
- Norway
- Sweden
- Estonia
- Russian Federation
- Latvia
- Denmark
- Lithuania
- United Kingdom
- Netherlands
- Ireland
- Poland
- Germany
- Belgium
- Czech Republic
- Ukraine
- Slovakia
- Luxembourg
- Moldova, Republic of
- Austria
- France
- Switzerland
- Romania
- Slovenia
- Croatia
- Serbia
- Bosnia & Herzegovina
- Bulgaria
- Italy
- Macedonia, the Former Yugoslav Republic of
- Spain
- Greece
- Israel
Sponsors
This event is part of the EGA work program and as such is sponsored by:-
- Actelion
- Amicus Therapeutics
- Eurordis
- Genzyme - a Sanofi Company
- Pfizer
- Shire
